The effects of rabeprazole on metformin pharmacokinetics and pharmacodynamics in Chinese healthy volunteers

Nathan, 2009, Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care, 32, 193, 10.2337/dc08-9025 Adler, 2009, Guideline Development G. Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidance, BMJ, 338, b1668, 10.1136/bmj.b1668 Ozturk, 2014, Insulin sensitizers for the treatment of non-alcoholic fatty liver disease, World J Hepatol, 6, 199, 10.4254/wjh.v6.i4.199 Urso, 2002, Metformin in non-alcoholic steatohepatitis, Lancet, 359, 355, 10.1016/S0140-6736(02)07566-9 Kirpichnikov, 2002, Metformin: an update, Ann Intern Med, 137, 25, 10.7326/0003-4819-137-1-200207020-00009 Stumvoll, 1995, Metabolic effects of metformin in non-insulin-dependent diabetes mellitus, N Engl J Med, 333, 550, 10.1056/NEJM199508313330903 Tosca, 2011, Metformin decreases GnRH- and activin-induced gonadotropin secretion in rat pituitary cells: potential involvement of adenosine 5' monophosphate-activated protein kinase (PRKA), Biol Reprod, 84, 351, 10.1095/biolreprod.110.087023 Poon, 2003, Metformin protects against carbon tetrachloride hepatotoxicity in mice, J Pharmacol Sci, 93, 501, 10.1254/jphs.93.501 Fujihara, 2015, Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo, Int J Oncol, 46, 2172, 10.3892/ijo.2015.2903 Hwang, 2015, Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis, Asian Pac J Cancer Prev, 16, 595, 10.7314/APJCP.2015.16.2.595 Gorboulev, 1997, Cloning and characterization of two human polyspecific organic cation transporters, DNA Cell Biol, 16, 871, 10.1089/dna.1997.16.871 Zhang, 1997, Cloning and functional expression of a human liver organic cation transporter, Mol Pharmacol, 51, 913, 10.1124/mol.51.6.913 Sirtori, 1978, Disposition of metformin (N,N-dimethylbiguanide) in man, Clin Pharmacol Ther, 24, 683, 10.1002/cpt1978246683 Stage, 2015, A comprehensive review of drug–drug interactions with metformin, Clin Pharmacokinet, 54, 811, 10.1007/s40262-015-0270-6 Kido, 2011, Profiling of a prescription drug library for potential renal drug–drug interactions mediated by the organic cation transporter 2, J Med Chem, 54, 4548, 10.1021/jm2001629 Nies, 2011, Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs), PLoS One, 6, e22163, 10.1371/journal.pone.0022163 Bolen, 2007, Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus, Ann Intern Med, 147, 386, 10.7326/0003-4819-147-6-200709180-00178 Li, 2013, Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs), Toxicol Appl Pharmacol, 273, 100, 10.1016/j.taap.2013.08.024 Scarpello, 2008, Metformin therapy and clinical uses, Diab Vasc Dis Res, 5, 157, 10.3132/dvdr.2008.027 Pawlyk, 2014, Metformin pharmacogenomics: current status and future directions, Diabetes, 63, 2590, 10.2337/db13-1367 Yoon, 2013, Influences of organic cation transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects, AAPS J, 15, 571, 10.1208/s12248-013-9460-z Chen, 2010, Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin, Pharmacogenet Genomics, 20, 687, 10.1097/FPC.0b013e32833fe789 Kim, 2014, Effects of proton pump inhibitors on metformin pharmacokinetics and pharmacodynamics, Drug Metab Dispos, 42, 1174, 10.1124/dmd.113.055616 Ding, 2014, The effect of lansoprazole, an OCT inhibitor, on metformin pharmacokinetics in healthy subjects, Eur J Clin Pharmacol, 70, 141, 10.1007/s00228-013-1604-7 Graham, 2011, Clinical pharmacokinetics of metformin, Clin Pharmacokinet, 50, 81, 10.2165/11534750-000000000-00000 Sambol, 1996, Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus, J Clin Pharmacol, 36, 1012, 10.1177/009127009603601105 Gao, 2013, Effect of combined treatment with clozapine and metformin on fasting blood glucose, insulin level, and expression of the glucose transporter-2 (GLUT2) in Sprague–Dawley rats, Shanghai Arch Psychiatry, 25, 149